195 related articles for article (PubMed ID: 24686883)
1. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study.
Koffeman AR; Valkhoff VE; Celik S; W't Jong G; Sturkenboom MC; Bindels PJ; van der Lei J; Luijsterburg PA; Bierma-Zeinstra SM
Br J Gen Pract; 2014 Apr; 64(621):e191-8. PubMed ID: 24686883
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal symptoms in NSAID users in an 'average risk population': results of a large population-based study in randomly selected Dutch inhabitants.
Tielemans MM; van Rossum LG; Eikendal T; Focks JJ; Laheij RJ; Jansen JB; van Oijen MG
Int J Clin Pract; 2014 Apr; 68(4):512-9. PubMed ID: 24499203
[TBL] [Abstract][Full Text] [Related]
3. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
Thomas J; Straus WL; Bloom BS
Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235
[TBL] [Abstract][Full Text] [Related]
4. Use of gastrointestinal prophylaxis in NSAID patients: a cross sectional study in community pharmacies.
López-Pintor E; Lumbreras B
Int J Clin Pharm; 2011 Apr; 33(2):155-64. PubMed ID: 21394571
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics.
Moore N; Scheiman JM
Postgrad Med; 2018 Mar; 130(2):188-199. PubMed ID: 29417856
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist intervention reduces gastropathy risk in patients using NSAIDs.
Ibañez-Cuevas V; Lopez-Briz E; Guardiola-Chorro MT;
Pharm World Sci; 2008 Dec; 30(6):947-54. PubMed ID: 18932013
[TBL] [Abstract][Full Text] [Related]
7. Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis.
Delaney JA; Biggs ML; Kronmal RA; Psaty BM
Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):83-9. PubMed ID: 21182156
[TBL] [Abstract][Full Text] [Related]
8. Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use.
Stosic R; Dunagan F; Palmer H; Fowler T; Adams I
Int J Pharm Pract; 2011 Aug; 19(4):236-45. PubMed ID: 21733011
[TBL] [Abstract][Full Text] [Related]
9. Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.
Duong M; Salvo F; Pariente A; Abouelfath A; Lassalle R; Droz C; Blin P; Moore N
Br J Clin Pharmacol; 2014 May; 77(5):887-95. PubMed ID: 24102791
[TBL] [Abstract][Full Text] [Related]
10. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs.
Wilcox CM; Cryer B; Triadafilopoulos G
J Rheumatol; 2005 Nov; 32(11):2218-24. PubMed ID: 16265706
[TBL] [Abstract][Full Text] [Related]
11. The safety of drugs for OTC use: what evidence is required for an NSAID switch?
MacDonald TM; Beard K; Bruppacher R; Hasford J; Lewis M; Logan RF; McNaughton D; Tubert-Bitter P; Van Ganse E; Moore N
Pharmacoepidemiol Drug Saf; 2002; 11(7):577-84. PubMed ID: 12462134
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
Biskupiak JE; Brixner DI; Howard K; Oderda GM
J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
[TBL] [Abstract][Full Text] [Related]
13. Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior.
Fry RB; Ray MN; Cobaugh DJ; Weissman NW; Kiefe CI; Shewchuk RM; Saag KG; Curtis JR; Allison JJ
Arthritis Rheum; 2007 Dec; 57(8):1539-45. PubMed ID: 18050227
[TBL] [Abstract][Full Text] [Related]
14. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
Lewis JD; Kimmel SE; Localio AR; Metz DC; Farrar JT; Nessel L; Brensinger C; McGibney K; Strom BL
Gastroenterology; 2005 Dec; 129(6):1865-74. PubMed ID: 16344055
[TBL] [Abstract][Full Text] [Related]
15. NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.
Pilotto A; Franceschi M; Leandro G; Di Mario F;
Drugs Aging; 2003; 20(9):701-10. PubMed ID: 12831293
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System.
Singh G
Am J Ther; 2000 Mar; 7(2):115-21. PubMed ID: 11319579
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users.
Teichert M; Griens F; Buijs E; Wensing M; De Smet PA
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):382-9. PubMed ID: 24535837
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.
Layton D; Souverein PC; Heerdink ER; Shakir SA; Egberts AC
Drug Saf; 2008; 31(2):143-58. PubMed ID: 18217790
[TBL] [Abstract][Full Text] [Related]
19. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.
Johnell K; Fastbom J
Clin Drug Investig; 2008; 28(11):687-95. PubMed ID: 18840011
[TBL] [Abstract][Full Text] [Related]
20. A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned.
Miller MJ; Allison JJ; Cobaugh DJ; Ray MN; Saag KG
J Eval Clin Pract; 2014 Oct; 20(5):638-48. PubMed ID: 24916786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
